2018
DOI: 10.1007/s12098-018-2807-9
|View full text |Cite
|
Sign up to set email alerts
|

Alström Syndrome Presenting as Isolated Dilated Cardiomyopathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
17
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(17 citation statements)
references
References 8 publications
0
17
0
Order By: Relevance
“…Patients with AS rarely live >40 years ( 22 ). At present, there is no specific treatment for AS, but early diagnosis and intervention can alleviate the progress of the disease phenotypes and improve the survival period and quality of life of patients ( 2 ).…”
Section: Discussionmentioning
confidence: 99%
“…Patients with AS rarely live >40 years ( 22 ). At present, there is no specific treatment for AS, but early diagnosis and intervention can alleviate the progress of the disease phenotypes and improve the survival period and quality of life of patients ( 2 ).…”
Section: Discussionmentioning
confidence: 99%
“…Hearing loss is reported in 89% of patients with a mean age of onset of 5 years (Marshall et al, 2005). Other atypical presentations of ALMS have been reported and include a case of putative isolated cardiomyopathy in a 2-month old child followed up until the age of 4.5 months (Nerakh and Ranganath, 2019). The infant did, however, develop significant weight gain (>95th centile; +3 SD) in the short follow up period (up to 4.5 months) and no formal visual assessments were conducted (Nerakh and Ranganath, 2019).…”
Section: Discussionmentioning
confidence: 99%
“…Other atypical presentations of ALMS have been reported and include a case of putative isolated cardiomyopathy in a 2-month old child followed up until the age of 4.5 months (Nerakh and Ranganath, 2019). The infant did, however, develop significant weight gain (>95th centile; +3 SD) in the short follow up period (up to 4.5 months) and no formal visual assessments were conducted (Nerakh and Ranganath, 2019). In this case, molecular analysis confirmed two novel compound heterozygous truncating variations in ALMS1.…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, the phenotype of AS partly overlaps with that of the other main ciliopathy, Bardet-Biedl syndrome (BBS), and differential diagnosis is often made by excluding clinical manifestations specific to BBS [ 26 ]. Atypical cases with non-syndromic retinal dystrophy or isolated cardiomyopathy due to variants in ALMS1 have also been reported [ 27 , 28 ]. The development of high-throughput sequencing technologies, such as whole-genome or exome sequencing, offers an exceptionally valuable screening tool for obtaining clear genetic diagnoses and identifying disease-causing gene variants.…”
Section: Introductionmentioning
confidence: 99%